These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 34368227)
1. Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer. Dong B; Liang J; Li D; Song W; Song J; Zhu M; Zhao S; Ma Y; Yang T Front Mol Biosci; 2021; 8():688298. PubMed ID: 34368227 [No Abstract] [Full Text] [Related]
2. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer. Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T Front Genet; 2021; 12():696912. PubMed ID: 34512722 [No Abstract] [Full Text] [Related]
3. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma. Chen L; Lin J; Wen Y; Chen Y; Chen CB Front Oncol; 2023; 13():1291720. PubMed ID: 38023241 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787 [TBL] [Abstract][Full Text] [Related]
6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
7. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer. Tan Z; Fu S; Zuo J; Wang J; Wang H Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832 [TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y Front Oncol; 2021; 11():686044. PubMed ID: 34422642 [TBL] [Abstract][Full Text] [Related]
9. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer. Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related]
11. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. Zhu S; Zhao Q; Fan Y; Tang C BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825 [TBL] [Abstract][Full Text] [Related]
12. Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer. Cui Y; Feng H; Liu J; Wu J; Zhu R; Huang R; Yan J Front Mol Biosci; 2022; 9():1009168. PubMed ID: 36158580 [No Abstract] [Full Text] [Related]
13. Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis. Cai D; Zhou Z; Wei G; Wu P; Kong G Front Genet; 2022; 13():952369. PubMed ID: 36118856 [No Abstract] [Full Text] [Related]
14. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer. Tang R; Wang H; Liu J; Song L; Hou H; Liu M; Wang J; Wang J Eur J Med Res; 2024 Feb; 29(1):112. PubMed ID: 38336764 [TBL] [Abstract][Full Text] [Related]
15. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer. Pan G; Xie H; Xia Y Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer. Gao X; Cai J Front Genet; 2022; 13():865204. PubMed ID: 35571063 [No Abstract] [Full Text] [Related]
17. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. Chen F; Wang Q; Zhou Y BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397 [TBL] [Abstract][Full Text] [Related]
18. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
19. Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer. Wu Y; Liu Y; He A; Guan B; He S; Zhang C; Kang Z; Gong Y; Li X; Zhou L Front Genet; 2020; 11():992. PubMed ID: 32983230 [TBL] [Abstract][Full Text] [Related]
20. A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database. Hu J; Wang L; Li L; Wang Y; Bi J BMC Cancer; 2022 Nov; 22(1):1158. PubMed ID: 36357874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]